Related Experiment Videos
Characterization of two lipoproteins in Pasteurella multocida
Miranda Lo1, John D Boyce, Ian W Wilkie
1Bacterial Pathogenesis Research Group, Department of Microbiology, Monash University, Melbourne,. 3800, Vic, Australia.
Microbes and Infection
|January 24, 2004
Summary
Researchers investigated Pasteurella multocida lipoproteins GlpQ and PCP for their potential to induce immunity. Vaccination with these lipoproteins did not protect mice or chickens against P. multocida infection.
Area of Science:
- Bacteriology
- Immunology
- Molecular Biology
Background:
- In vivo expression technology (IVET) identified Pasteurella multocida genes upregulated during host infection.
- Two identified genes encode proteins similar to Haemophilus influenzae lipoproteins (Protein D and PCP), known to induce heterologous immunity.
- This study focuses on Pasteurella multocida GlpQ and PCP lipoprotein homologues.
Purpose of the Study:
- To investigate the P. multocida GlpQ and PCP homologues as potential vaccine candidates.
- To determine if these lipoproteins can induce protective immunity against P. multocida infection.
Main Methods:
- Confirmed GlpQ and PCP as lipoproteins using globomycin inhibition of post-translational processing.
- Assessed GlpQ enzyme activity and confirmed its functional homology.
- Determined surface exposure of PCP and GlpQ using surface immunoprecipitation.
- Vaccinated mice and chickens with both non-lipidated and lipidated forms of GlpQ and PCP expressed in E. coli.
Main Results:
- GlpQ exhibited glycerophosphodiester phosphodiesterase activity, confirming it as a functional homologue.
- PCP was found to be surface-exposed, while GlpQ was not.
- Vaccination with non-lipidated or lipidated GlpQ and PCP did not confer protection against P. multocida challenge in mice or chickens.
Conclusions:
- While GlpQ and PCP are confirmed lipoproteins and PCP is surface-exposed, they do not induce protective immunity against P. multocida in the tested models.
- Further research is needed to identify effective vaccine targets against P. multocida.